评估虚拟增强磁共振成像在鼻咽癌放射治疗中的应用:针对原发肿瘤大体靶区勾画的回顾性分析
本研究回顾性纳入3个肿瘤中心348例经活检证实的鼻咽癌患者,利用288例训练多模态引导协同神经网络(MMgSN-Net)合成虚拟增强磁共振成像(VCE-MRI),并在60例中独立评估。结果显示VCE-MRI与真实增强MRI的区分准确率平均为31.67%,肿瘤与正常组织界面清晰度无显著差异,肿瘤侵犯风险区域对比增强真实性准确率为85.8%,计划靶区平均剂量学差异小于1 Gy。作者结论认为VCE-MRI在鼻咽癌肿瘤勾画中高度有望替代钆基增强MRI。
要点
- VCE-MRI与CE-MRI的平均区分准确率为31.67%,图像质量高度相似。
- 肿瘤与正常组织界面清晰度在VCE-MRI与CE-MRI间无显著差异。
- 肿瘤侵犯风险区域对比增强真实性准确率为85.8%,计划靶区平均剂量学差异小于1 Gy。
核心结论
- 作者结论认为VCE-MRI在鼻咽癌患者肿瘤勾画中高度有望替代钆基增强MRI。
研究设计与样本
- 回顾性研究,从3个肿瘤中心检索348例经活检证实的鼻咽癌患者的T1加权、T2加权MRI、钆基增强MRI和计划CT。
- 使用288例患者训练多模态引导协同神经网络(MMgSN-Net)合成VCE-MRI,并用60例患者独立评估。
- 由3名委员会认证的放射肿瘤学家和2名医学物理师参与图像质量评估、靶区勾画辅助和治疗计划有效性三方面临床评估。
主要发现
- VCE-MRI与CE-MRI的平均区分准确率为31.67%。
- VCE-MRI与CE-MRI在肿瘤与正常组织界面清晰度方面无显著差异。
- 肿瘤侵犯风险区域对比增强真实性准确率为85.8%。
- 图像质量评估结果提示VCE-MRI的图像质量与真实CE-MRI高度相似。
- 计划靶区的平均剂量学差异小于1 Gy。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the potential of virtual contrast-enhanced magnetic resonance imaging (VCE-MRI) for gross-tumor-volume (GTV) delineation of nasopharyngeal carcinoma (NPC) using multi-institutional data. METHODS AND MATERIALS: This study retrospectively retrieved T1-weighted (T1w), T2-weighted (T2w) MRI, gadolinium-based contrast-enhanced MRI (CE-MRI), and planning computed tomography (CT) of 348 biopsy-proven NPC patients from 3 oncology centers. A multimodality-guided synergistic neural network (MMgSN-Net) was trained using 288 patients to leverage complementary features in T1w and T2w MRI for VCE-MRI synthesis, which was independently evaluated using 60 patients. Three board-certified radiation oncologists and 2 medical physicists participated in clinical evaluations in 3 aspects: image quality assessment of the synthetic VCE-MRI, VCE-MRI in assisting target volume delineation, and effectiveness of VCE-MRI-based contours in treatment planning. The image quality assessment includes distinguishability between VCE-MRI and CE-MRI, clarity of tumor-to-normal tissue interface, and veracity of contrast enhancement in tumor invasion risk areas. Primary tumor delineation and treatment planning were manually performed by radiation oncologists and medical physicists, respectively. RESULTS: The mean accuracy to distinguish VCE-MRI from CE-MRI was 31.67%; no significant difference was observed in the clarity of tumor-to-normal tissue interface between VCE-MRI and CE-MRI; for the veracity of contrast enhancement in tumor invasion risk areas, an accuracy of 85.8% was obtained. The image quality assessment results suggest that the image quality of VCE-MRI is highly similar to real CE-MRI. The mean dosimetric difference of planning target volumes was less than 1 Gy. CONCLUSIONS: The VCE-MRI is highly promising to replace the use of gadolinium-based CE-MRI in tumor delineation of NPC patients.
引用
- Li W, Zhao D, Zeng G, et al. Evaluating Virtual Contrast-Enhanced Magnetic Resonance Imaging in Nasopharyngeal Carcinoma Radiation Therapy: A Retrospective Analysis for Primary Gross Tumor Delineation. Int J Radiat Oncol Biol Phys. 2024. PMID: 38964419. doi:10.1016/j.ijrobp.2024.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。